
Our founder Enric Roche selected as one of the top 100 doctors in Spain
We are very proud that our founder Dr. Enric Roche has been selected as one of the top 100 doctors
We are very proud that our founder Dr. Enric Roche has been selected as one of the top 100 doctors
Vincent Riambau has presented an update on our Cutneedle® at this year’s VEITHsimposium.
Our Varixio® project has been selected for funding by the EU’s Horizon 2020 research and innovation programme. The project is
Our experience with Varixio® presented at the Proof of Concept Event organized by Eurecat. The presentation was addressed to young
VB Device’s team proud of BioExperts’ acknowledgment The BioExpert Network is a network of experts in the sectors of life
Cutneedle 1st in human Clinical Trial at Hospital Clínica Barcelona
La Vanguardia has featured our partnership with Eurecat Eurocat is a Technology Centre (a member of Tecnio) that will help
Both of VB Device’s developments have been selected for presentation at the 40th Charing Cross Meeting next April. CX is probably the most prestigious vascular meeting in Europe and the oldest specialty meeting.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 887677
Necessary cookies only include cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function.
Analytical cookiesFederico Grego has more than 20 years of experience in the pharmaceutical industry (LETI Pharma), in senior management positions, coupled with 4 years of experience in investment banking (HSBC). He also has extensive experience in the biomedical entrepreneurship sector helping to promote various projects, including Cytovation AS, Allero Therapeutics, and Nexkin Medical, among others. He is an economist (Tufts University), MBA (IESE) and AMP Certificate (Harvard).